Ganglioside Nanocluster-Targeting Peptidyl Inhibitor Prevents Amyloid β Fibril Formation on the Neuronal Membrane
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ganglioside Nanocluster-Targeting Peptidyl Inhibitor Prevents Amyloid β Fibril Formation on the Neuronal Membrane
Authors
Keywords
-
Journal
ACS Chemical Neuroscience
Volume 13, Issue 13, Pages 1868-1876
Publisher
American Chemical Society (ACS)
Online
2022-06-22
DOI
10.1021/acschemneuro.2c00047
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heterogeneous Ganglioside-Enriched Nanoclusters with Different Densities in Membrane Rafts Detected by a Peptidyl Molecular Probe
- (2021) Teruhiko Matsubara et al. LANGMUIR
- A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
- (2019) Francesco Panza et al. Nature Reviews Neurology
- Alzheimer disease and aducanumab: adjusting our approach
- (2019) Dennis J. Selkoe Nature Reviews Neurology
- Amyloid β fibrils assembled on ganglioside-enriched membranes contain both parallel β-sheets and turns
- (2018) Teruhiko Matsubara et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Responsibility of lipid compositions for the amyloid ß assembly induced by ganglioside nanoclusters in mouse synaptosomal membranes
- (2018) Teruhiko Matsubara et al. POLYMER JOURNAL
- An in vitro paradigm to assess potential anti-Aβ antibodies for Alzheimer’s disease
- (2018) Ming Jin et al. Nature Communications
- Size and Shape of Amyloid Fibrils Induced by Ganglioside Nanoclusters: Role of Sialyl Oligosaccharide in Fibril Formation
- (2017) Teruhiko Matsubara et al. LANGMUIR
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Structural and dynamic views of GM1 ganglioside
- (2015) Maho Yagi-Utsumi et al. GLYCOCONJUGATE JOURNAL
- Imbalance in Fatty-Acid-Chain Length of Gangliosides Triggers Alzheimer Amyloid Deposition in the Precuneus
- (2015) Naoto Oikawa et al. PLoS One
- Neuroimaging and Other Biomarkers for Alzheimer's Disease: The Changing Landscape of Early Detection
- (2013) Shannon L. Risacher et al. Annual Review of Clinical Psychology
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Density of GM1 in Nanoclusters Is a Critical Factor in the Formation of a Spherical Assembly of Amyloid β-Protein on Synaptic Plasma Membranes
- (2013) Teruhiko Matsubara et al. LANGMUIR
- Pathological significance of ganglioside clusters in Alzheimer’s disease
- (2011) Katsuhiko Yanagisawa JOURNAL OF NEUROCHEMISTRY
- Amyloid oligomers: formation and toxicity of Aβ oligomers
- (2010) Masafumi Sakono et al. FEBS Journal
- Sialic Acid-Mimic Peptides As Hemagglutinin Inhibitors for Anti-Influenza Therapy
- (2010) Teruhiko Matsubara et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide
- (2010) Ethan A. Merritt et al. PROTEIN SCIENCE
- Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution
- (2010) Harry Levine PROTEIN SCIENCE
- Inhibition of Influenza Virus Infections by Sialylgalactose-Binding Peptides Selected from a Phage Library
- (2009) Teruhiko Matsubara et al. JOURNAL OF MEDICINAL CHEMISTRY
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
- (2008) Dagmar E Ehrnhoefer et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started